| Metabolic dysfunction drives a mechanistically distinct proinflammatory phenotype in adipose tissue macrophages M Kratz, BR Coats, KB Hisert, D Hagman, V Mutskov, E Peris, ... Cell metabolism 20 (4), 614-625, 2014 | 778 | 2014 |
| Restoring cystic fibrosis transmembrane conductance regulator function reduces airway bacteria and inflammation in people with cystic fibrosis and chronic lung infections KB Hisert, SL Heltshe, C Pope, P Jorth, X Wu, RM Edwards, M Radey, ... American journal of respiratory and critical care medicine 195 (12), 1617-1628, 2017 | 331 | 2017 |
| Regional isolation drives bacterial diversification within cystic fibrosis lungs P Jorth, BJ Staudinger, X Wu, KB Hisert, H Hayden, J Garudathri, ... Cell host & microbe 18 (3), 307-319, 2015 | 324 | 2015 |
| A glutamate‐alanine‐leucine (EAL) domain protein of Salmonella controls bacterial survival in mice, antioxidant defence and killing of macrophages: role of cyclic … KB Hisert, M MacCoss, MU Shiloh, KH Darwin, S Singh, RA Jones, S Ehrt, ... Molecular microbiology 56 (5), 1234-1245, 2005 | 183 | 2005 |
| Host and pathogen response to bacteriophage engineered against Mycobacterium abscessus lung infection JA Nick, RM Dedrick, AL Gray, EK Vladar, BE Smith, KG Freeman, ... Cell 185 (11), 1860-1874. e12, 2022 | 124 | 2022 |
| Pseudomonas aeruginosa aggregates in cystic fibrosis sputum produce exopolysaccharides that likely impede current therapies LK Jennings, JE Dreifus, C Reichhardt, KM Storek, PR Secor, DJ Wozniak, ... Cell reports 34 (8), 2021 | 114 | 2021 |
| Filamentous Bacteriophage Produced by Pseudomonas aeruginosa Alters the Inflammatory Response and Promotes Noninvasive Infection In Vivo PR Secor, LA Michaels, KS Smigiel, MG Rohani, LK Jennings, KB Hisert, ... Infection and immunity 85 (1), 10.1128/iai. 00648-16, 2017 | 106 | 2017 |
| Spontaneous phthiocerol dimycocerosate-deficient variants of Mycobacterium tuberculosis are susceptible to gamma interferon-mediated immunity MA Kirksey, AD Tischler, R Siméone, KB Hisert, S Uplekar, C Guilhot, ... Infection and immunity 79 (7), 2829-2838, 2011 | 91 | 2011 |
| Inhibition of interleukin 2 signaling and signal transducer and activator of transcription (STAT) 5 activation during T cell receptor–mediated feedback inhibition of T cell … IH Lee, WP Li, KB Hisert, LB Ivashkiv The Journal of experimental medicine 190 (9), 1263-1274, 1999 | 84 | 1999 |
| Identification of Mycobacterium tuberculosis Counterimmune (cim) Mutants in Immunodeficient Mice by Differential Screening KB Hisert, MA Kirksey, JE Gomez, AO Sousa, JS Cox, WR Jacobs Jr, ... Infection and immunity 72 (9), 5315-5321, 2004 | 67 | 2004 |
| Acute administration of ivacaftor to people with cystic fibrosis and a G551D-CFTR mutation reveals smooth muscle abnormalities RJ Adam, KB Hisert, JD Dodd, B Grogan, JL Launspach, JK Barnes, ... JCI insight 1 (4), 2016 | 42 | 2016 |
| Ivacaftor-induced proteomic changes suggest monocyte defects may contribute to the pathogenesis of cystic fibrosis KB Hisert, KQ Schoenfelt, G Cooke, B Grogan, JL Launspach, ... American journal of respiratory cell and molecular biology 54 (4), 594-597, 2016 | 42 | 2016 |
| In Vivo Proteome of Pseudomonas aeruginosa in Airways of Cystic Fibrosis Patients X Wu, RJ Siehnel, J Garudathri, BJ Staudinger, KB Hisert, EA Ozer, ... Journal of proteome research 18 (6), 2601-2612, 2019 | 32 | 2019 |
| Infection control strategies that successfully controlled an outbreak of Mycobacterium abscessus at a cystic fibrosis center SG Kapnadak, KB Hisert, PS Pottinger, AP Limaye, ML Aitken American Journal of Infection Control 44 (2), 154-159, 2016 | 31 | 2016 |
| CFTR modulator therapy enhances peripheral blood monocyte contributions to immune responses in people with cystic fibrosis KB Hisert, TP Birkland, KQ Schoenfelt, ME Long, B Grogan, S Carter, ... Frontiers in pharmacology 11, 1219, 2020 | 29 | 2020 |
| Restoring CFTR function reduces airway bacteria and inflammation in people with cystic fibrosis and chronic lung infections KB Hisert, SL Heltshe, C Pope, P Jorth, X Wu, RM Edwards, M Radey, ... Am J Respir Crit Care Med 195 (12), 1617-1628, 2017 | 29 | 2017 |
| The NOSE study (nasal ointment for Staphylococcus aureus eradication): a randomized controlled trial of monthly mupirocin in HIV-infected individuals RJ Gordon, N Chez, H Jia, B Zeller, M Sobieszczyk, C Brennan, KB Hisert, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 55 (4), 466-472, 2010 | 26 | 2010 |
| Ivacaftor decreases monocyte sensitivity to interferon-γ in people with cystic fibrosis KB Hisert, TP Birkland, KQ Schoenfelt, ME Long, B Grogan, S Carter, ... ERJ open research 6 (2), 2020 | 20 | 2020 |
| The impact of highly effective modulator therapy on cystic fibrosis microbiology and inflammation LJ Caverly, SA Riquelme, KB Hisert Clinics in chest medicine 43 (4), 647-665, 2022 | 16 | 2022 |
| Understanding and addressing the needs of people with cystic fibrosis in the era of CFTR modulator therapy KB Hisert, SE Birket, JP Clancy, DG Downey, JF Engelhardt, I Fajac, ... The lancet respiratory medicine 11 (10), 916-931, 2023 | 12 | 2023 |
